Thymosin Alpha-1 vs Thymalin

Both trace back to thymus research. Thymosin alpha-1 is a single, sequenced peptide made synthetically; thymalin is a mixture of peptides extracted from calf thymus, used in Russia.

HPLC tested · JanoshikJanoshik CertificatesNationwide DeliveryResearch Only

🧪

Thymosin Alpha-1

A 28-amino-acid thymic peptide that modulates T-cell and dendritic-cell function, registered as a medicine in a number of countries.

BEST STUDIED FOR

Repair & immune

Read the cited profile →

🧪

	Thymosin Alpha-1	Thymalin
The key difference	Single defined synthetic peptide	Calf-thymus peptide extract
Class	Repair & immune	Bioregulators
Mechanism	Thymosin α1 acts on innate and adaptive immunity — reported to signal through Toll-like receptors on dendritic cells and to promote T-cell maturation — which is why it is studied as an immune "modifier" in infections, vaccines and oncology.	Thymalin is described as restoring T-cell function and differentiation.
Status	Approved (thymalfasin) in over 30 countries, mainly for hepatitis B/C and as an immune adjuvant; not registered in South Africa. Ongoing trials in oncology.	Registered in Russia; outside that, evidence is largely from one research school and published mostly in Russian-language or niche journals.
Reported safety signals	Reviews describe a favourable tolerability record in clinical use; injection-site discomfort is the most cited effect.	Long clinical use in Russia is reported by its developers; independent safety data are limited.
A key study	A comprehensive review of thymosin α1 in immunocompromised states, malignancy and vaccine response. (World J Virol 2020, PMID 33362999)	Reported that thymalin activated differentiation of human haematopoietic stem cells in vitro. (Bull Exp Biol Med 2020, PMID 33237528)

Thymosin alpha-1 offers a defined molecule and international trials; thymalin a Russian clinical tradition. Both are discussed here strictly as research compounds; nothing on this page is medical advice or a dosing guide.

REFERENCES (PUBMED)

[Thymosin Alpha-1] Thymosin alpha 1: A comprehensive review of the literature — World J Virol 2020. PMID 33362999
[Thymosin Alpha-1] Historical review of thymosin α 1 in infectious diseases — Expert Opin Biol Ther 2015. PMID 26098768
[Thymosin Alpha-1] Aging and Thymosin Alpha-1 — Int J Mol Sci 2025. PMID 41373628
[Thymalin] Thymalin: Activation of Differentiation of Human Hematopoietic Stem Cells — Bull Exp Biol Med 2020. PMID 33237528
[Thymalin] The Influence of KE and EW Dipeptides in the Composition of the Thymalin Drug on Gene Expression and Protein Synthesis Involved in the Pathogenesis of COVID-19 — Int J Mol Sci 2023. PMID 37686182
[Thymalin] [Geroprotective effect of thymalin and epithalamin] — Adv Gerontol 2002. PMID 12577695

FREQUENTLY ASKED

What is the difference between Thymosin Alpha-1 and Thymalin?

Both trace back to thymus research. Thymosin alpha-1 is a single, sequenced peptide made synthetically; thymalin is a mixture of peptides extracted from calf thymus, used in Russia.

What is the regulatory status of Thymosin Alpha-1 and Thymalin?

Thymosin Alpha-1: Approved (thymalfasin) in over 30 countries, mainly for hepatitis B/C and as an immune adjuvant; not registered in South Africa. Ongoing trials in oncology. Thymalin: Registered in Russia; outside that, evidence is largely from one research school and published mostly in Russian-language or niche journals.

What safety signals have been reported?

Thymosin Alpha-1: Reviews describe a favourable tolerability record in clinical use; injection-site discomfort is the most cited effect. Thymalin: Long clinical use in Russia is reported by its developers; independent safety data are limited.

Which studies is this comparison based on?

For Thymosin Alpha-1: “Thymosin alpha 1: A comprehensive review of the literature” (PMID 33362999); “Historical review of thymosin α 1 in infectious diseases” (PMID 26098768); “Aging and Thymosin Alpha-1” (PMID 41373628). For Thymalin: “Thymalin: Activation of Differentiation of Human Hematopoietic Stem Cells” (PMID 33237528); “The Influence of KE and EW Dipeptides in the Composition of the Thymalin Drug on Gene Expression and Protein Synthesis Involved in the Pathogenesis of COVID-19” (PMID 37686182); “[Geroprotective effect of thymalin and epithalamin]” (PMID 12577695).